SI1401445T1 - Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila - Google Patents

Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila

Info

Publication number
SI1401445T1
SI1401445T1 SI200230431T SI200230431T SI1401445T1 SI 1401445 T1 SI1401445 T1 SI 1401445T1 SI 200230431 T SI200230431 T SI 200230431T SI 200230431 T SI200230431 T SI 200230431T SI 1401445 T1 SI1401445 T1 SI 1401445T1
Authority
SI
Slovenia
Prior art keywords
production
drug
anticholinergic
crystalline
crystalline anticholinergic
Prior art date
Application number
SI200230431T
Other languages
English (en)
Inventor
Peter Sieger
Ulrike Werthmann
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of SI1401445T1 publication Critical patent/SI1401445T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SI200230431T 2001-06-22 2002-06-08 Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila SI1401445T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10129710 2001-06-22
DE10215436 2002-04-08
PCT/EP2002/006291 WO2003000265A1 (de) 2001-06-22 2002-06-08 Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (1)

Publication Number Publication Date
SI1401445T1 true SI1401445T1 (sl) 2007-02-28

Family

ID=26009556

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230431T SI1401445T1 (sl) 2001-06-22 2002-06-08 Kristalinicen antiholinergik, postopek za njegovo pripravo in njegova uporaba za pripravo zdravila

Country Status (38)

Country Link
EP (1) EP1401445B1 (sl)
JP (1) JP2005504015A (sl)
KR (2) KR100971616B1 (sl)
CN (1) CN100586948C (sl)
AR (1) AR037491A1 (sl)
AT (1) ATE337006T1 (sl)
AU (1) AU2002345016B2 (sl)
BG (1) BG66303B1 (sl)
BR (1) BR0210537A (sl)
CA (1) CA2450961C (sl)
CO (1) CO5550423A2 (sl)
CY (1) CY1105223T1 (sl)
CZ (1) CZ302786B6 (sl)
DE (1) DE50207943D1 (sl)
DK (1) DK1401445T3 (sl)
EA (1) EA005813B1 (sl)
EE (1) EE05316B1 (sl)
EG (1) EG24851A (sl)
ES (1) ES2271280T3 (sl)
HK (1) HK1068540A1 (sl)
HR (1) HRP20031066B1 (sl)
HU (1) HUP0400333A3 (sl)
IL (2) IL159238A0 (sl)
ME (1) ME00412B (sl)
MX (1) MXPA03011718A (sl)
MY (1) MY122779A (sl)
NO (1) NO334301B1 (sl)
NZ (1) NZ530690A (sl)
PE (2) PE20081305A1 (sl)
PL (1) PL208137B1 (sl)
PT (1) PT1401445E (sl)
RS (1) RS50441B (sl)
SA (1) SA02230255B1 (sl)
SI (1) SI1401445T1 (sl)
SK (1) SK287262B6 (sl)
TW (2) TW200617007A (sl)
UY (1) UY27342A1 (sl)
WO (1) WO2003000265A1 (sl)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
ATE453641T1 (de) * 2003-11-03 2010-01-15 Boehringer Ingelheim Int Neues kristallines anhydrat mit anticholinerger wirksamkeit
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
EP2422786B1 (de) 2004-04-22 2014-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (de) 2004-08-11 2009-05-14 Boehringer Ingelheim Pharma Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
KR20080007645A (ko) 2005-04-28 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 염증성 질환 치료용 신규 화합물
NZ563596A (en) * 2005-05-02 2011-01-28 Boehringer Ingelheim Int Crystalline form of tiotropium bromide anhydrate
AU2006243239A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
WO2007020227A1 (de) 2005-08-15 2007-02-22 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
MX2007009988A (es) * 2005-12-19 2008-02-22 Sicor Inc Formas novedosas de bromuro de tiotropio y procesos para su preparacion.
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
NZ563488A (en) 2006-04-19 2010-04-30 Boehringer Ingelheim Int Dihydrothienopyrimidines for the treatment of inflammatory diseases
JP2010500318A (ja) 2006-08-07 2010-01-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療用医薬組成物
PE20080610A1 (es) 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2009050248A1 (de) 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh Substituierte piperidino-dihydrothienopyrimidine
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20120053164A1 (en) 2008-12-19 2012-03-01 Boehringer Ingelheim International Gmbh Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
GEP20146124B (en) 2009-12-17 2014-07-25 Boehringer Ingelheim Int Novel ccr2 receptor antagonists and usage thereof
EP2513086B1 (en) 2009-12-17 2015-04-29 Boehringer Ingelheim International GmbH Novel antagonists for ccr2 and uses thereof
EA201201052A1 (ru) 2010-01-29 2013-02-28 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2受容体アンタゴニスト、その製造方法及び薬物としてのその使用
EP2571870B1 (en) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Ccr2 antagonists and uses thereof
JP5636094B2 (ja) 2010-05-25 2014-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr2受容体アンタゴニスト
WO2011151251A1 (en) 2010-06-01 2011-12-08 Boehringer Ingelheim International Gmbh New ccr2 antagonists
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
JP5959537B2 (ja) 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201101897A2 (tr) 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal madde
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
WO2012171863A1 (en) 2011-06-16 2012-12-20 Boehringer Ingelheim International Gmbh New selective ccr2 antagonists
WO2013010839A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Novel and selective ccr2 antagonists
JP5860960B2 (ja) 2011-07-26 2016-02-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換キノリン類及び医薬としてのそれらの使用
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
PE20190181A1 (es) 2011-11-25 2019-02-01 Adverio Pharma Gmbh Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
PT106142B (pt) * 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
BR112015009654A2 (pt) 2012-11-05 2017-07-04 Zentiva Ks métodos para a estabilização de solvatos micronizados ou moídos de brometo de tiotrópio e preparar o solvato de brometo de tiotrópio, solvato de brometo de tiotrópio, e, uso de solvatos estabilizados
CN104341412A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵结晶的制备方法
LT3119772T (lt) 2014-03-19 2019-08-26 Boehringer Ingelheim International Gmbh Heteroarilo sik inhibitoriai
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2016065028A1 (en) 2014-10-21 2016-04-28 Ariad Pharmaceuticals, Inc. Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
WO2017138896A1 (en) * 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU2002214996B2 (en) * 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Also Published As

Publication number Publication date
EP1401445A1 (de) 2004-03-31
NO20035696D0 (no) 2003-12-19
CO5550423A2 (es) 2005-08-31
ATE337006T1 (de) 2006-09-15
WO2003000265A1 (de) 2003-01-03
BG66303B1 (bg) 2013-03-29
HRP20031066A2 (en) 2004-04-30
ME00412B (me) 2011-10-10
BG108440A (en) 2004-08-31
NZ530690A (en) 2005-05-27
KR20090031638A (ko) 2009-03-26
BR0210537A (pt) 2004-06-22
HK1068540A1 (en) 2005-04-29
NO334301B1 (no) 2014-02-03
JP2005504015A (ja) 2005-02-10
TW200617007A (en) 2006-06-01
HRP20031066B1 (en) 2011-10-31
HUP0400333A2 (hu) 2004-12-28
CZ302786B6 (cs) 2011-11-09
KR101011353B1 (ko) 2011-01-28
SK522004A3 (en) 2004-06-08
TWI261589B (en) 2006-09-11
MEP62008A (en) 2011-05-10
DK1401445T3 (da) 2006-11-27
EA005813B1 (ru) 2005-06-30
YU99703A (sh) 2006-05-25
AR037491A1 (es) 2004-11-17
CZ2004120A3 (cs) 2004-05-12
UY27342A1 (es) 2003-02-28
PE20081305A1 (es) 2008-10-01
SK287262B6 (sk) 2010-04-07
CY1105223T1 (el) 2010-03-03
CA2450961A1 (en) 2003-01-03
KR100971616B1 (ko) 2010-07-22
RS50441B (sr) 2010-03-02
PE20030130A1 (es) 2003-04-02
AU2002345016B2 (en) 2008-04-17
CN1520294A (zh) 2004-08-11
EE200400029A (et) 2004-04-15
PL208137B1 (pl) 2011-03-31
ES2271280T3 (es) 2007-04-16
EA200301293A1 (ru) 2004-08-26
CN100586948C (zh) 2010-02-03
EG24851A (en) 2010-10-27
DE50207943D1 (de) 2006-10-05
PT1401445E (pt) 2006-10-31
MXPA03011718A (es) 2004-12-06
MY122779A (en) 2006-05-31
EE05316B1 (et) 2010-08-16
IL159238A (en) 2010-04-15
SA02230255B1 (ar) 2006-10-31
EP1401445B1 (de) 2006-08-23
IL159238A0 (en) 2004-06-01
PL364489A1 (en) 2004-12-13
KR20040018285A (ko) 2004-03-02
HUP0400333A3 (en) 2012-10-29
CA2450961C (en) 2010-03-30

Similar Documents

Publication Publication Date Title
HK1068540A1 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002345016A1 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
IL155335A0 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU2002214996A1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU1397502A (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
AU2002213975A1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
HK1077818A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
IL153273A0 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
IL191790A0 (en) Xanthine derivatives, production and use thereof as a medicament
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
TWI318211B (en) Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
AU6222901A (en) Cyclipostins, a method for their production and the use of the same
ZA200308591B (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug.
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
HUP0302989A3 (en) Benzamidine derivatives and process for production thereof
HUP0203593A3 (en) Amycomycin, a process for its production and its use as a pharmaceutical
SI1294682T1 (sl) Acilfenilsečninski derivati, postopki za njihovo pripravo in njihova uporaba kot zdravila
SI1456212T1 (sl) Derivati 6-aminomorfinana, postopek za njihovo izdelavo in njihova uporaba
SI1372670T1 (sl) Kaloporozidni derivati, prostopek za njihovo pripravo in njihova uporaba